LACTOSE
Hepatic Encephalopathy
Centro Regional para el Estudio de las Enfermedades DigestivasUNKNOWNPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 81/ 100
Competitive context
23 Active assets in the Hepatic Encephalopathy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Rifaximin General Hospital of Shenyang Military Region | Phase 4 | BBB |
L-Ornithine L-Aspartate Jinnah Postgraduate Medical Centre | Phase 4 | BBB |
Lactulose General Hospital of Shenyang Military Region | Phase 4 | BBB |
Normal Human Serum Albumin General Hospital of Shenyang Military Region | Phase 4 | BB |
L-Ornithine-L-Aspartate Qurratul Ain Jamil | Phase 4 | BB |
View all 46 →
Same molecule, other indications
LACTOSE is also rated in:
metabolic dysfunction-associated steatotic liver diseaseDormant
BB
Indicative · Phase 3
64 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →